Higher vitamin D levels and working from home were linked to lower COVID-19 risk in people with MS, while more housemates and jobs with outside contact raised the risk.
Researchers looked at 149 people with MS who had COVID-19 and 292 similar people with MS who did not. People with higher blood vitamin D were less likely to have had COVID-19; vitamin D is a nutrient your body makes from sunlight and helps the immune system. Surprisingly, active smokers were less often found in the COVID group, but this may be because smokers were less likely to be health workers and had different exposures. Living with more people in the same home raised the chance of getting COVID-19, like how a cold spreads more easily in a crowded house. Jobs that need contact with many people, especially health care work, were linked to a higher chance of getting COVID-19 compared to jobs done remotely or at home.
People with MS and their caregivers should care because these findings point to practical ways to lower infection risk, such as improving vitamin D levels and reducing unnecessary exposure. Think of vitamin D like a small shield that helps your immune system work better; getting tested and treating low vitamin D might help, but ask your doctor first. If possible, working from home or reducing close contact at work can lower infection risk, similar to staying out of a crowded bus during flu season. Caregivers and family members who live with someone with MS should know that more housemates raise spread risk, so steady hygiene and rooming arrangements matter. Health care workers with MS should be especially careful because their job increases exposure, so masking, vaccination, and protective measures are important steps.
This was a single-center, retrospective study, which means it looked back at past records from one clinic and so may not apply everywhere. The surprising link with smoking likely reflects other differences (like job type) and does not mean smoking is safe—smoking still harms health in many ways. The study shows associations, not proof of cause and effect, so changes like starting vitamin D or changing work should be discussed with your health care team.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds a brain‑seeking CD4 killer cell tied to MS and CMV exposure that may resist some treatme
Read More5/1/2026
Study shows after optic neuritis the ganglion cell layer (GCL) loses more tissue than the inner plex
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds specific spinal fluid proteins tied to early nerve damage in active MS, highlighting imm
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.